Oral Niacin Can Increase Intraocular Pressure
Authors:
- Daniela S. Monteiro de BarrosDBDaniela S. Monteiro de Barros
- Julia B. V. Kuntz NavarroJNJulia B. V. Kuntz Navarro
- Daniel G. J. FreitasDFDaniel G. J. Freitas
- Moataz E. GheithMGMoataz E. Gheith
- Ghada A. SiamGSGhada A. Siam
- George L. SpaethGSGeorge L. Spaeth
- 1 July 2008
- journal article
- case report
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 39 (4) , 341-342
Abstract
The intraocular pressure of a 73-year-old man with a history of primary open-angle glaucoma had been approximately 21 and 17 mm Hg in the right and left eyes, respectively, while taking latanoprost 0.005% and dorzolamide hydrochloride 2%. When taking 500 mg of oral niacin (also known as vitamin B3 or nicotinic acid), his intraocular pressure increased to 37 and 27 mm Hg in the right and left eyes, respectively, on one occasion. On reexamination, the intraocular pressure had increased to 28 and 23 mm Hg in the right and left eyes, respectively. Each time the niacin was stopped, the intraocular pressure decreased to the original levels. [Ophthalmic Surg Lasers Imaging 2008;39:341–342.]Keywords
This publication has 7 references indexed in Scilit:
- Effect of Niacin on Retinal Vascular Diameter in Patients with Age-Related Macular DegenerationCurrent Eye Research, 2006
- A comparison of the circadian rhythm of intraocular pressure in primary chronic angle closure glaucoma, primary open angle glaucoma and normal eyesIndian Journal Of Ophthalmology, 2005
- Effect of niacin on the choroidal circulation of patients with age related macular degenerationBritish Journal of Ophthalmology, 2004
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportCirculation, 2002
- Macular Edema Associated With Nicotinic Acid (Niacin)JAMA, 1998
- Adverse ocular effects associated with niacin therapy.British Journal of Ophthalmology, 1995
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981